4th Quarter - Report

AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Firm
Client
Income
—
Expenses
$70,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Support for increasing cancer research funding, including support for the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 (H.R. 3293).

LobbyistCovered position, as disclosed
DAVID ADLER —
SHANDI ELISE BARNEY —
EMILY WILSON —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Nuclear Regulatory Commission (NRC); SENATE

Bills named: H.R. 3293 (111th)

Homeland Security HOM

To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2009 (H.R. 3276).

LobbyistCovered position, as disclosed
DAVID ADLER —
RICHARD J MARTIN —
EMILY WILSON —

Contacted: Veterans Affairs, Dept of (VA); Nuclear Regulatory Commission (NRC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Energy, Dept of

Bills named: H.R. 3276 (111th)

Veterans VET

Review of brachytherapy treatments at Philadelphia VA and testimony to promote brachytherapy as a safe cancer treatment option. Support for the Veterans' Health and Radiation Safety Act (H.R. 4062) to ensure oversight of radiation oncology procedures are carried out in an effective and efficient manner while maintaining patient safety.

LobbyistCovered position, as disclosed
DAVID ADLER —
RICHARD J MARTIN —
EMILY WILSON —

Contacted: Nuclear Regulatory Commission (NRC); SENATE; Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Bills named: H.R. 4062 (111th)

Medicare/Medicaid MMM

Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments, including support for the Medicare Physician Fairness Act of 2009 (S. 1776) and the Medicare Physician Payment Reform Act (H.R. 3961). Advocacy to stop the 19 percent cut for radiation oncology services proposed by CMS in the 2010 proposed physician fee schedule. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Comprehensive Cancer Care Improvement Act of 2009 (H.R. 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Legislation to support structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for H.R. 3095 to provide Medicare coverage for cancer patients. Oppose Gregg amendment to health care reform requiring public reporting of quality data. Letter to CMS regarding provider enrollment issues.

LobbyistCovered position, as disclosed
DAVID ADLER —
RICHARD J MARTIN —
EMILY WILSON —

Contacted: Executive Office of the President (EOP); Energy, Dept of; SENATE; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC)

Bills named: S. 1776 (111th), H.R. 3961 (111th), H.R. 3095 (111th), H.R. 1844 (111th)

Health Issues HCR

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200), the Patient Protection and Affordable Care Act (H.R. 3590), and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2009 (H.R. 3276). Letter to FDA supporting regulation to ensure the validity of in vitro diagnostic tests.

LobbyistCovered position, as disclosed
DAVID ADLER —
RICHARD J MARTIN —
EMILY WILSON —

Contacted: Veterans Affairs, Dept of (VA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Energy, Dept of; Nuclear Regulatory Commission (NRC)

Bills named: H.R. 716 (111th), H.R. 3590 (111th), H.R. 3276 (111th), H.R. 3200 (111th), S. 488 (111th), S. 1796 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.